Molecules/RELATLIMAB

RELATLIMAB

Molecular Identity

AntibodyApprovedFirst approved 2022

Mechanism of action: Lymphocyte activation gene 3 protein inhibitor

Molecular Formula

0.00

Molecular Weight

g/mol

BMS-986016RELATLIMABRELATLIMAB COMPONENT OF BMS-986213RELATLIMAB COMPONENT OF OPDUALAG -RMBWRELATLIMAB RMBWRELATLIMAB-RMBW

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Trials and conditions connected to RELATLIMAB

Loading drug network...